Supplementary Figure 1 from PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN

Authors :: Sabina Signoretti
Toni K. Choueiri
Gordon J. Freeman
Ying Huang
Evelyn Wang
Thomas Powles
Michael J. Morris
Robert J. Motzer
Daniel J. George
Bernard Escudier
Rebecca B. Jennings
Amin H. Nassar
Ziad Bakouny
Miriam Ficial
David A. Braun
Wanling Xie
Abdallah Flaifel
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Figure S1 shows PD-L1 positive and negative staining

Tools